Pharmaceutical industry
TRACON Pharmaceuticals, a biotechnology company, has entered into a Cooperative Research and Development Agreement with the National Cancer Institute to collaborate on the study of TRC105 for the treatment of prostate cancer. TRC105 targets CD105, an endothelial cell membrane receptor essential for angiogenesis, which is critical for tumor growth and
Pharmaceutical industry
Nutra Pharma, a biotechnology company, has announced its intent to launch Nyloxin Rx, a prescription medicine for the treatment of severe chronic pain. Developed by ReceptoPharm, Nutra Pharma's drug discovery subsidiary, Nyloxin Rx uses a novel mechanism from cobra venom peptides to relieve pain without relying on opioids.
Pharmaceutical industry
Biovail Corporation and ACADIA Pharmaceuticals have announced an update on their Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which they are pursuing in collaboration. Despite disappointing top-line results from the first Phase III PDP trial, the parties remain committed to the successful development of pimavanserin
Pharmaceutical industry
Global mergers and acquisitions (M&A) activity saw a significant boost yesterday as Xerox announced plans to buy American IT outsourcing company Affiliated Computer Services (ACS) for $6.4bn (pounds 4bn). The deal, along with two other major announcements, helped the FTSE 100 jump 1.64% to 5165.7.
Pharmaceutical industry
German Chancellor Angela Merkel secured her second term, while multinational corporations were involved in significant deals, as German voters chose a centre-right government. In this period, major corporations such as Xerox, Johnson & Johnson, Solvay, and Unicom, made substantial investments and partnerships in the tech, healthcare, and pharmaceutical sectors. As
Pharmaceutical industry
Crystal Research Associates' chief executive officer and cofounder, Jeffrey Kraws, was recently interviewed by Bloomberg Television, discussing the progress of a potential HIV vaccine in clinical testing and the challenges facing the development of H1N1 flu vaccines. Mr. Kraws highlighted recent advancements in vaccine technologies at biotechnology companies such
Pharmaceutical industry
Advanced Cell Technology Inc. (ACTC) has been featured in an investment report by StockPreacher.com, providing financial and investment analysis, analyst consensus, and industry information. The report is of particular interest to other biotech companies, including Geron Corp. (GERN), StemCells Inc. (STEM), and Aastrom Biosciences Inc. (ASTM). The report highlights
Pharmaceutical industry
Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) has successfully attained FDA self-affirmed GRAS (Generally Recognized as Safe) status for its OnlySweet stevia extracts. This achievement marks a significant milestone in the company's partnership with WILD Flavors, a leading provider of natural and health-enhancing ingredients to the food and beverage
Pharmaceutical industry
Beacon Equity, a leading provider of small-cap investment research, has released an in-depth report on Facet Biotech Corp. (Nasdaq:FACT), a biotechnology company focused on the development of oncology therapeutics. The report comes on the heels of the company's rejection of an unsolicited takeover bid from Biogen Idec
Pharmaceutical industry
Exelixis Inc., a pharmaceutical company focused on developing novel small molecule drug therapies for cancer treatment, is poised for significant growth. The company's lead drug candidate, XL184, has a 90% chance of reaching commercialization, according to FDA statistics. With a market potential of over $1 billion, Exelixis Inc.
Pharmaceutical industry
ImmunoCellular Therapeutics, a clinical-stage biotechnology company, has entered into a research and license option agreement with Roche Group, one of the world's leading research-focused healthcare groups. The agreement regards ImmunCellular's ICT-69 antibody, which has shown promise in the diagnosis and treatment of multiple myeloma and ovarian
Pharmaceutical industry
Sinovac Biotech Ltd. (SVA), a Chinese vaccine maker, has been featured in a recent investment report by StockPreacher.com, highlighting its financial and investment analysis, analyst consensus, and pertinent industry information. The report is particularly relevant for other biotechnology companies, including Amgen Inc. (AMGN), Biogen Idec Inc. (BIIB), Genzyme Corp.
